Ovarian Cancer Treatment and Concerns
Occasionally patients will come in requesting a "cancer test" to screen them for
"female" cancer. They are usually referring to the CA-125 blood test. There
have been many stories written in magazines and viewed on television encouraging women
to see their physician to have this test performed and check them for cancer. This
article is written to help correct some common myths about checking for "female" cancer and the
appropriate way to be evaluated.
Ovarian Cancer: CA-125 and Ultrasound
First, it is important to understand the difference between screening tests and diagnostic tests.
Screening tests are the familiar procedures that are recommended for all healthy people, such as
for all women, cholesterol assay, dental exams, blood pressure checks for all adults, etc. Screening
tests are cheap and easy to do, and they have, by definition, been proven to save lives because they
detect common mild or early abnormalities that, if treated, prevent bigger problems such as cervical
cancer, heart attack, tooth loss, stroke, etc. The screening test does not provide much information
in itself other than to say that further investigation of the situation by diagnostic testing is needed
to see if a real problem exists and to see what treatment may be needed.
When Should an Ovarian Cancer Test Be Prescribed?
A diagnostic test is prescribed in response to an abnormal finding from a screening test or for
a patient with a significant symptom or significant abnormal finding on an exam by a clinician. Most
blood tests, x-rays, and procedures are considered diagnostic tests and the results must then be
reviewed in the context of a long list of possible abnormalities.
The CA-125 blood test, an ultrasound, and the "total body scan" are all considered diagnostic
tests, not screening tests, because they don't provide highly useful information when used by the
larger population which has no abnormal finding of a screen, abnormal finding on an exam or abnormal
symptom. Administering diagnostic tests to the larger population has been shown to provide few people
value because of the low likelihood of finding an abnormality, often results in many false positive
findings, and costs much.
One example would be taking a trip to Las Vegas in order to make money by
gambling. Most everyone loses money, but one or two find great wealth. These three tests mentioned above
have been researched well as proposed screening tests for the larger healthy population, and the
results consistently show that there is little value to most in their use without symptoms, exam
findings, or screening test indications. Many women find value in the reassurance that the above tests
if normal will provide, and they can afford to pay the fee for this reassurance.
shows that there are likely to be very few revelations by diagnostic tests used in a screening context
that will save peoples lives or result in dramatic benefit. Everyone knows of some one person, from
thousands taking the Total Body Scan, in whom a mass is found and whose subsequent surgery saved their
Ovarian Cancer; more detailed information »
This PDF covers all of this material:
Regarding Ovarian Cancer, CA-125 and Ultrasound
- CA-125: Good for Diagnosis, Not useful in Screening
- Ultrasound: a valuable, non-surgical diagnostic tool
- Borderline Tumors of the Ovary
- Therapy for Borderline Ovarian Tumors
- Malignant Epithelial Ovarian Neoplasms CAP LETTERS
- The FIGO Staging for Primary Carcinoma of the Ovary (1985)
- Mechanism of spread:
- Surgical Management and Staging
- ChemoTherapy for invasive epithelial carcinoma of the ovary
- Second Look: Not standard
- Metastatic Disease to Ovary
- Pseudomyxomatous Peritonei Carcinoma
- Pseudomyxoma ovarii-conditin limited to ovary
Please Note: To read or print the PDF document you need Adobe® Reader®. A free program is available here; the download information will appear in a new Web browser window.